Cronos Group

Cronos Group is a Canadian manufacturer of canabis. It operates as a diversified and vertically integrated company. The company offers platforms for the production and distribution of medical marijuana, and cultivates cannabis oil. Cronos Group serves customers in Canada.
Cronos Group stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Cronos Group balance sheet

Report period2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Cronos Group cash flows

Report period2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Cronos Group multipliers

Report period2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Cronos Group profitability

Report period2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Cronos Group assets
Cronos Group cash flows

Cronos Group shares

TickerNameTypeNominal valueISINPrice
CRON:USCronos Group, Inc.Common share-CA22717L1013$2.045
Cronos Group news
10.05.2022
Cronos Group's GAAP loss for 3 months of 2022 was $32.653 million, down 4.9 times from $161.625 million in the previous year. Revenue increased 98.5% to $25.033 million compared to $12.611 million a year earlier.
Source: {source} pictogram thecronosgroup.gcs-web.com
Pictogram next
01.03.2022
Cronos Group's GAAP loss for 2021 was $397.204 million, up 5.27 times from $75.27 million in the previous year. Revenue increased 59.3% to $74.435 million from $46.719 million a year earlier.
Source: {source} pictogram thecronosgroup.gcs-web.com
Pictogram next
18.02.2022
Cronos Group's GAAP loss for 9 months of 2021 was $263.312 million, compared to a profit of $36.442 million in the previous year. Revenue increased 68.9% to $58.092 million from $34.397 million a year earlier.
Source: {source} pictogram ir.thecronosgroup.com
Pictogram next
06.08.2021
Cronos Group's GAAP loss for six months of 2021 was $104.85 million, up 2.3 times from $32.022 million in the previous year. Revenue increased 61.3% to $33.502 million from $20.776 million a year earlier.
Source: {source} pictogram thecronosgroup.gcs-web.com
Pictogram next
All Cronos Group news
General information
Company nameCronos Group
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address720 KING STREET W SUITE 320 TORONTO A6 M5V 2T3 (416) 504-0004
Mailing address720 KING STREET W SUITE 320 TORONTO A6 M5V 2T3
Websitethecronosgroup.com
Information disclosurewww.sec.gov